Efficacy of Difelikefalin in Subjects With Moderate-to-Severe Chronic Kidney Disease–Associated Pruritus: Pooled Subgroup Analysis of KALM-1 and KALM-2. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 6, p. s77, 2021. DOI: 10.25251/skin.5.supp.77. Disponível em: https://skin.dermsquared.com/skin/article/view/1428. Acesso em: 20 apr. 2025.